ArticleCureus2025
Elderly Patients With Inflammatory Polyarthritis: The Importance of Including Remitting Seronegative Symmetrical Synovitis With Pitting Edema (RS3PE) in the Differential Diagnosis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Remitting symmetrical seronegative synovitis with pitting edema (RS3PE) is a rare seronegative inflammatory arthritis that primarily affects older adults. Clinical features include acute onset, symmetric polyarthritis in the upper extremities, pitting edema in the dorsum of the hands, age of onset > 60 years, and rapid response to medium-dose steroids. Rheumatoid factor and joint erosions are typically absent. Despite its favorable prognosis, RS3PE is frequently misdiagnosed in older adults due to overlapping comorbidities, posing diagnostic challenges. We present a case of a 92-year-old male with recurrent RS3PE who initially presented with acute symmetric upper extremity edema, polyarthritis, and a dramatic response to prednisone. His symptoms recurred three years after remission, which is unusual. As the population ages and life expectancy increases, it is likely clinicians will see an increase in the incidence of RS3PE. Understanding the clinical nuances and subtleties in distinguishing this condition from other inflammatory and crystalline arthropathies will lead to improved diagnostic accuracy and management. Furthermore, the high association of RS3PE with concurrent malignancy warrants age-appropriate cancer screening and a careful balance of diagnostic investigation and goals of care in those with advanced age. Exploration of "what matters most," one of the pillars of age-friendly care, should guide clinicians on how best to proceed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.